Showing results (151-160 of 201) with videos related to
Sort By:
Pageof 21
Nature Communications|December 11, 2021
Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunctionCaroline Diorio, Rawan Shraim, Laura A Vella, et al.Blood|January 22, 2025
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemiaFatemeh Alikarami, Hongbo M Xie, Simone S Riedel, et al.Haematologica|January 30, 2025
Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologistsDong Li, Sarah K Tasian, Gerald Wertheim, et al.Cancer|February 24, 2022
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group reportSumit Gupta, David T Teachey, Zhiguo Chen, et al.The Journal of Allergy and Clinical Immunology|September 20, 2024
Serum cytokine panels in pediatric clinical practicePaul M Gallo, Jihwan Kim, Kevin O McNerney, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical TrialStephan Kadauke, Regina M Myers, Yimei Li, et al.Nature Communications|November 21, 2025
Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemiaCaroline R M Wiggers, Eugene Y Cho, Merve Ozdemir, et al.Nature Cancer|November 25, 2024
A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemiaJason Xu, Changya Chen, Jonathan H Sussman, et al.Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.Journal of the Pediatric Infectious Diseases Society|December 2, 2020
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)Elizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, et al.Pageof 21